31 - 36 out of 36Page size: 10
  1. 2019

  2. The natalizumab wearing-off effect: End of natalizumab cycle, recurrence of MS symptoms

    van Kempen, Z. L. E., Doesburg, D., Dekker, I., Lissenberg-Witte, B. I., de Vries, A., Claessen, I. A., Brinke, A. T., Rispens, T. & Killestein, J., 2019, In: Neurology. 93, 17, p. e1579-e1586

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2018

  4. Response to "Letter to the editor on the paper: The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing"

    van Kempen, Z. L. E., Rispens, T. & Killestein, J., 2018, In: Multiple sclerosis (Houndmills, Basingstoke, England). 24, 6, p. 822-823

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  5. Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients

    Leurs, C. E., van Kempen, Z. L. E., Dekker, I., Balk, L. J., Wattjes, M. P., Rispens, T., Uitdehaag, B. M. J. & Killestein, J., 2018, In: Multiple sclerosis (Houndmills, Basingstoke, England). 24, 11, p. 1453-1460

    Research output: Contribution to journal › Article › Academic › peer-review

  6. The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing

    van Kempen, Z. L. E., Leurs, C. E., Witte, B. I., de Vries, A., Wattjes, M. P., Rispens, T. & Killestein, J., 2018, In: Multiple sclerosis (Houndmills, Basingstoke, England). 24, 6, p. 805-810

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2017

  8. John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients

    van Kempen, Z. L. E., Leurs, C. E., de Vries, A., Vennegoor, A., Rispens, T., Wattjes, M. P. & Killestein, J., 2017, In: European journal of neurology. 24, 9, p. 1196-1199

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations

    van Kempen, Z. L. E., Leurs, C. E., Vennegoor, A., Wattjes, M. P., Rispens, T., Uitdehaag, B. M. J. & Killestein, J., 2017, In: MULTIPLE SCLEROSIS JOURNAL. 23, 7, p. 995-999

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 Next

ID: 97640